vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and YORK WATER CO (YORW). Click either name above to swap in a different company.
YORK WATER CO is the larger business by last-quarter revenue ($19.4M vs $19.2M, roughly 1.0× Apyx Medical Corp). YORK WATER CO runs the higher net margin — 26.7% vs -6.8%, a 33.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 3.2%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 5.1%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
APYX vs YORW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $19.4M |
| Net Profit | $-1.3M | $5.2M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 33.2% |
| Net Margin | -6.8% | 26.7% |
| Revenue YoY | 34.7% | 3.2% |
| Net Profit YoY | 71.9% | 0.5% |
| EPS (diluted) | — | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $19.4M | ||
| Q3 25 | $12.9M | $20.2M | ||
| Q2 25 | $11.4M | $19.1M | ||
| Q1 25 | $9.4M | $18.3M | ||
| Q4 24 | $14.2M | $18.8M | ||
| Q3 24 | $11.5M | $19.6M | ||
| Q2 24 | $12.1M | $18.6M | ||
| Q1 24 | $10.2M | $17.5M |
| Q4 25 | $-1.3M | $5.2M | ||
| Q3 25 | $-2.0M | $6.2M | ||
| Q2 25 | $-3.8M | $5.1M | ||
| Q1 25 | $-4.2M | $3.6M | ||
| Q4 24 | $-4.6M | $5.1M | ||
| Q3 24 | $-4.7M | $5.9M | ||
| Q2 24 | $-6.6M | $5.0M | ||
| Q1 24 | $-7.6M | $4.3M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 33.2% | ||
| Q3 25 | -6.5% | 39.1% | ||
| Q2 25 | -22.6% | 37.1% | ||
| Q1 25 | -32.4% | 34.3% | ||
| Q4 24 | -21.4% | 35.8% | ||
| Q3 24 | -31.6% | 41.1% | ||
| Q2 24 | -45.7% | 37.9% | ||
| Q1 24 | -64.6% | 35.5% |
| Q4 25 | -6.8% | 26.7% | ||
| Q3 25 | -15.4% | 30.6% | ||
| Q2 25 | -33.2% | 26.5% | ||
| Q1 25 | -44.0% | 19.8% | ||
| Q4 24 | -32.5% | 27.4% | ||
| Q3 24 | -40.9% | 29.9% | ||
| Q2 24 | -54.0% | 26.8% | ||
| Q1 24 | -74.0% | 24.7% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $0.43 | ||
| Q2 25 | — | $0.35 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | $-0.19 | $0.35 | ||
| Q1 24 | $-0.22 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $1.0K |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $240.3M |
| Total Assets | $66.8M | $680.9M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $1.0K | ||
| Q3 25 | $25.1M | $1.0K | ||
| Q2 25 | $29.3M | $1.0K | ||
| Q1 25 | $31.0M | $1.0K | ||
| Q4 24 | $31.7M | $1.0K | ||
| Q3 24 | $28.0M | $1.0K | ||
| Q2 24 | $32.7M | $1.0K | ||
| Q1 24 | $37.3M | $3.3M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $240.3M | ||
| Q3 25 | $5.8M | $238.0M | ||
| Q2 25 | $7.3M | $234.6M | ||
| Q1 25 | $10.5M | $232.1M | ||
| Q4 24 | $14.2M | $231.2M | ||
| Q3 24 | $11.0M | $228.7M | ||
| Q2 24 | $14.7M | $225.4M | ||
| Q1 24 | $20.3M | $222.9M |
| Q4 25 | $66.8M | $680.9M | ||
| Q3 25 | $57.4M | $667.1M | ||
| Q2 25 | $58.2M | $653.7M | ||
| Q1 25 | $60.2M | $641.8M | ||
| Q4 24 | $64.8M | $633.5M | ||
| Q3 24 | $60.7M | $621.4M | ||
| Q2 24 | $65.4M | $610.4M | ||
| Q1 24 | $70.7M | $602.3M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $8.4M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $8.4M | ||
| Q3 25 | $-3.5M | $7.8M | ||
| Q2 25 | $-1.2M | $7.6M | ||
| Q1 25 | $-702.0K | $6.0M | ||
| Q4 24 | $-2.9M | $10.2M | ||
| Q3 24 | $-4.4M | $7.5M | ||
| Q2 24 | $-4.3M | $6.7M | ||
| Q1 24 | $-6.3M | $6.1M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
